Neurocognitive Impairment in Acute Respiratory Failure and Shock: Understanding the Role of Neuronal Excitotoxicity
急性呼吸衰竭和休克中的神经认知损伤:了解神经元兴奋性毒性的作用
基本信息
- 批准号:10383666
- 负责人:
- 金额:$ 17.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-04-15 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAcute respiratory failureAddressAdmission activityAdvisory CommitteesAnimal ModelAnimalsAreaAttentionBehaviorBenchmarkingBrainBrain InjuriesCardiopulmonaryClinicalClinical TrialsCognitionCohort StudiesComaCritical CareCritical IllnessDataDeliriumDementiaEarly treatmentElectroencephalographyEnrollmentFailureFundingFutureGlial Fibrillary Acidic ProteinGlutamatesHippocampus (Brain)HomeostasisHospitalizationHospitalsHumanImageImpaired cognitionInjuryIntensive Care UnitsKnowledgeKynurenineLaboratoriesLeadLinkMeasuresMechanical ventilationMentorsMetabolismMethodsMolecularMorbidity - disease rateNeurocognitiveNeurocognitive DeficitNeurologicNeuron-Specific EnolaseNeuronal InjuryNeuronsOutcomeOxygenPathogenesisPathway interactionsPatientsPharmacological TreatmentPharmacologyPhasePhenotypePlasmaPopulationPositioning AttributePublic HealthRecoveryResearchResearch DesignResearch PersonnelResearch TrainingRiskRisk FactorsRoleScientistSedation procedureSepsisServicesShockSubgroupSurvivorsSyndromeTechniquesTestingTimeTrainingTraining ProgramsTranslationsTryptophanclinical riskclinical trial enrollmentcognitive neurosciencecognitive testingcohortconfusion assessment methoddesignexcitotoxicityfrontal lobehigh riskinjury and repairinnovationmortalityneuronal patterningneuroprotectionnew therapeutic targetpatient orientedpatient stratificationpredictive modelingpredictive toolspreventprospectiverisk stratificationseptic patientsstatisticssystemic inflammatory responsetargeted treatmenttherapeutic target
项目摘要
Project Summary
Cardiopulmonary failure due to acute respiratory failure or shock is the most common syndrome necessitating
intensive care unit services. Patients with cardiopulmonary failure often develop burdensome neurocognitive
sequelae that threaten both short and long-term outcomes. In the short-term, these patients frequently develop
delirium, a severe alteration in attention and cognition that is associated with increased mortality as well as
longer durations of mechanical ventilation and ICU stay. After recovering, 1 in 4 survivors suffer long-term
cognitive impairment (LTCI) similar to dementia. Despite the impact delirium and LTCI have on these patients,
there are currently no proven pharmacologic therapies aimed at preventing these neurocognitive sequelae.
Sepsis accounts for over 1 million hospitalizations per year and is the most common cause of cardiopulmonary
failure, making it an ideal population to investigate the underlying mechanisms of delirium and LTCI. Our group
and others have shown that delirium and LTCI are characterized by injury to the hippocampus and frontal
cortex. Animal models show a similar pattern of neuronal injury, and implicate alterations in glutamate
homeostasis and kynurenine metabolism as key downstream pathways of neuronal injury that can be
therapeutically targeted. However, a lack of data on these pathways in humans and an inability to identify
which patients would most likely benefit from early therapy are key knowledge gaps limiting the translation of
these findings to clinical trials. To address these knowledge gaps, this proposal will investigate the role of
glutamate and kynurenine dysregulation in an ongoing cohort of septic patients with cardiopulmonary failure
who are followed prospectively for delirium and subsequent cognitive impairment. In addition to the proposed
research, the candidate will engage in a rigorous training program designed to support his transition into an
independent scientist. The specific objectives of this proposal are to: 1) determine the association of glutamate
and kynurenine dysregulation with delirium and cognitive impairment in septic patients with cardiopulmonary
failure, 2) identify risk factors for cognitive impairment and develop a predictive tool that could be used to guide
enrollment in future clinical trials, 3) train the candidate in cognitive neuroscience, mechanisms of neuronal
injury and repair, cohort study design and conduct, molecular laboratory techniques and advanced statistics,
and 4) provide the candidate with individualized mentoring to support his transition to independence. The
candidate's attainment of specific research and training benchmarks will be regularly reviewed by his mentors
and advisory committee. Through completion of this proposal, the candidate will enhance our understanding of
the underlying mechanisms of delirium and LTCI in these patients, and position himself to successfully
compete for R01 funding of future projects aimed at testing neuroprotective therapies.
项目摘要
由于急性呼吸衰竭或休克引起的心力衰竭是最常见的综合征,
重症监护室服务。心肺功能衰竭患者通常会出现神经认知负担
影响短期和长期结果的后遗症。在短期内,这些患者经常会出现
谵妄,注意力和认知的严重改变,与死亡率增加以及
机械通气和ICU停留时间更长。康复后,四分之一的幸存者长期遭受
认知障碍(LTCI),类似于痴呆。尽管谵妄和LTCI对这些患者有影响,
目前还没有经过证实的旨在预防这些神经认知后遗症的药物疗法。
脓毒症占每年超过100万次住院治疗,并且是心肺功能衰竭的最常见原因。
失败,使其成为研究谵妄和LTCI潜在机制的理想人群。我们集团
其他研究表明,谵妄和LTCI的特征是海马和额叶损伤,
皮层动物模型显示出类似的神经元损伤模式,并暗示谷氨酸的改变。
稳态和犬尿氨酸代谢作为神经元损伤的关键下游途径,
治疗靶向。然而,由于缺乏关于人类这些途径的数据,
哪些患者最有可能从早期治疗中受益是限制翻译的关键知识差距,
将这些发现用于临床试验。为了弥补这些知识差距,本提案将探讨以下方面的作用:
心肺衰竭脓毒症患者中谷氨酸和犬尿氨酸失调的研究
他们被前瞻性地跟踪谵妄和随后的认知障碍。除了拟议的
研究,候选人将参加一个严格的培训计划,旨在支持他过渡到一个
独立科学家本提案的具体目标是:1)确定谷氨酸的关联
与犬尿氨酸失调伴谵妄和认知功能障碍的心肺功能衰竭患者
失败,2)识别认知障碍的风险因素,并开发可用于指导的预测工具
在未来的临床试验中招募,3)在认知神经科学,神经元的机制,
损伤和修复,队列研究设计和进行,分子实验室技术和先进的统计学,
(4)为候选人提供个性化辅导,以支持其向独立过渡。的
导师会定期检讨申请人在研究及训练方面的表现
咨询委员会。通过完成这份建议书,候选人将加深我们对以下方面的理解:
这些患者中谵妄和LTCI的潜在机制,并将自己定位为成功地
竞争R01基金的未来项目旨在测试神经保护疗法。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Clinical Impact of an Electronic Dashboard and Alert System for Sedation Minimization and Ventilator Liberation: A Before-After Study.
- DOI:10.1097/cce.0000000000000057
- 发表时间:2019-10-01
- 期刊:
- 影响因子:0
- 作者:Anderson, Brian J;Do, David;Fuchs, Barry D
- 通讯作者:Fuchs, Barry D
Self-reported poor quality of sleep in solid organ transplant: A systematic review.
- DOI:10.1016/j.trre.2021.100650
- 发表时间:2021-12
- 期刊:
- 影响因子:0
- 作者:Cordoza M;Koons B;Perlis ML;Anderson BJ;Diamond JM;Riegel B
- 通讯作者:Riegel B
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brian J. Anderson其他文献
Pharmacokinetics of Intraperitoneal Lidocaine for Sustained Postoperative Analgesia in Adults
- DOI:
10.1007/s13318-025-00948-1 - 发表时间:
2025-05-08 - 期刊:
- 影响因子:2.400
- 作者:
Kenyon W. Osborne;Wiremu S. MacFater;Brian J. Anderson;Darren Svirskis;Andrew G. Hill;Jacqueline A. Hannam - 通讯作者:
Jacqueline A. Hannam
No urine, no urinary clearance
- DOI:
10.1007/s00228-004-0777-5 - 发表时间:
2004-05-18 - 期刊:
- 影响因子:2.700
- 作者:
Brian J. Anderson;Nicholas H. G. Holford - 通讯作者:
Nicholas H. G. Holford
A prospective randomised single blinded study comparing harmonic scalpel tonsillectomy with bipolar tonsillectomy
- DOI:
10.1016/j.ijporl.2006.02.004 - 发表时间:
2006-08-01 - 期刊:
- 影响因子:
- 作者:
Matthew Leaper;Murali Mahadevan;David Vokes;Debby Sandow;Brian J. Anderson;Teena West - 通讯作者:
Teena West
Statistical thermodynamics model and empirical correlations for predicting mixed hydrate phase equilibria
- DOI:
10.1016/j.fluid.2014.03.010 - 发表时间:
2014-07-15 - 期刊:
- 影响因子:
- 作者:
Nagasree Garapati;Brian J. Anderson - 通讯作者:
Brian J. Anderson
Common Errors of Drug Administration in Infants
- DOI:
10.2165/00128072-199901020-00003 - 发表时间:
2012-08-31 - 期刊:
- 影响因子:3.300
- 作者:
Brian J. Anderson;John F. Ellis - 通讯作者:
John F. Ellis
Brian J. Anderson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brian J. Anderson', 18)}}的其他基金
Neurocognitive Impairment in Acute Respiratory Failure and Shock: Understanding the Role of Neuronal Excitotoxicity
急性呼吸衰竭和休克中的神经认知损伤:了解神经元兴奋性毒性的作用
- 批准号:
9898435 - 财政年份:2018
- 资助金额:
$ 17.61万 - 项目类别:
相似海外基金
Novel Digital Methods to Evaluate Functional and Pulmonary Outcomes following Pediatric Acute Respiratory Failure
评估小儿急性呼吸衰竭后功能和肺部结果的新型数字方法
- 批准号:
10724042 - 财政年份:2023
- 资助金额:
$ 17.61万 - 项目类别:
Optimizing Time-Limited Trials of Mechanical Ventilation in Acute Respiratory Failure: A Mixed Methods Observational Study
优化急性呼吸衰竭机械通气的限时试验:混合方法观察研究
- 批准号:
10633823 - 财政年份:2023
- 资助金额:
$ 17.61万 - 项目类别:
Use of Inter-Hospital Transfer Services in Critical Illness and Acute Respiratory Failure
在危重疾病和急性呼吸衰竭中使用医院间转运服务
- 批准号:
10739060 - 财政年份:2023
- 资助金额:
$ 17.61万 - 项目类别:
Strengthening implementation science in Acute Respiratory Failure using multilevel analysis of existing data
利用现有数据的多级分析加强急性呼吸衰竭的实施科学
- 批准号:
10731311 - 财政年份:2023
- 资助金额:
$ 17.61万 - 项目类别:
Identifying patient subgroups and processes of care that cause outcome differences following ICU vs. ward triage among patients with acute respiratory failure and sepsis
确定急性呼吸衰竭和脓毒症患者在 ICU 与病房分诊后导致结局差异的患者亚组和护理流程
- 批准号:
10734357 - 财政年份:2023
- 资助金额:
$ 17.61万 - 项目类别:
Temporal trends in quality indicators of palliative care for patients with chronic illness hospitalized with acute respiratory failure
因急性呼吸衰竭住院的慢性病患者姑息治疗质量指标的时间趋势
- 批准号:
10622756 - 财政年份:2023
- 资助金额:
$ 17.61万 - 项目类别:
Health expectations after acute respiratory failure in survivor-care partner dyads
幸存者护理伙伴二人组急性呼吸衰竭后的健康期望
- 批准号:
10732929 - 财政年份:2023
- 资助金额:
$ 17.61万 - 项目类别:
Association of patient characteristics and antibiotic timing with the development of acute respiratory failure in hospital-acquired sepsis
患者特征和抗生素使用时机与医院获得性脓毒症急性呼吸衰竭发展的关系
- 批准号:
10313769 - 财政年份:2022
- 资助金额:
$ 17.61万 - 项目类别:
Financial Hardship among Patients with Acute Respiratory Failure and their Family Member Caregivers: Understanding the Impact on Patient- and Family- Centered Outcomes
急性呼吸衰竭患者及其家庭成员护理人员的经济困难:了解对以患者和家庭为中心的结果的影响
- 批准号:
10413457 - 财政年份:2022
- 资助金额:
$ 17.61万 - 项目类别: